Bupropion vs Pembrolizumab

Bupropion vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Bupropion and Pembrolizumab.

Mechanism of Action

Bupropion: Norepinephrine-dopamine reuptake inhibitor (NDRI).

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Bupropion — 21 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Bupropion — C13H18ClNO.

Molecular Weight: Bupropion — 239.7420 g/mol.

Type: Bupropion — Small molecule; Pembrolizumab — Antibody.